Optics11 Life B.V.

Optics11 Life B.V. is an SME in Amsterdam, Netherlands that has taken part in 3 EU-funded projects since 2021, receiving €650k in EU funding.

EU funding received€650k
EU projects3
As coordinator0
Running now2
First EU project2021
Latest project2023
CountryNetherlands
EU registration (PIC)879702022
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Optics11 Life B.V.'s own share of each project, not the project's full budget.

  • Horizon 2020€405k · 1 project
  • Horizon Europe€245k · 2 projects

Projects

3 EU-funded projects, newest first. Each links to the official record.

  • MAGICPartner

    Next-generation models and genetic therapies for rare neuromuscular diseases

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €46ktheir share
  • iCarePartner

    Integrated assessment and Advanced Characterisation of Neuro-Nanotoxicity

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €199ktheir share
  • UroPrintPartner

    Urinary bladder bioprinting for fully autologous transplantation

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €405ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • nano-materials
  • neurology
  • tissue engineering
  • transplantation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime